Tesamorelin and Ipamorelin represent two of the most extensively studied compounds in growth hormone secretagogue research. While each has been examined independently across a substantial body of peer-reviewed literature, researchers have increasingly studied them in combination based on their complementary receptor targets and mechanistically distinct pathways to GH stimulation. This post provides a research-focused overview of both compounds individually and the rationale for studying them together.
Among the most consistently studied compound pairings in growth hormone secretagogue research, CJC-1295 (without DAC) and Ipamorelin represent two mechanistically distinct peptides that have been examined both individually and in combination. This post covers what peer-reviewed literature has explored regarding each compound’s mechanism, pharmacokinetic profile, and the rationale behind studying them together.
Delta Sleep-Inducing Peptide — more commonly referenced in research literature as DSIP — is a nine-amino acid neuropeptide that has been studied across a range of neurological and endocrine contexts since its initial isolation in the 1970s. This post provides a straightforward overview of what peer-reviewed research has explored regarding DSIP, with a focus on the mechanisms and study areas most relevant to current research interest.
